BRIEF published on 08/26/2026 at 23:10, 1 hour 38 minutes ago Biosidus Boosts Manufacturing to Enhance Global Agalsidase Beta Supply Biosidus Bioreactor Plant Biologics Production Agalsidase Beta Fabry Disease
BRIEF published on 08/26/2026 at 23:10, 1 hour 38 minutes ago Biosidus augmente sa production pour accroître l'approvisionnement mondial en bêta-agalsidase. Biosidus Agalsidase Beta Usine De Bioréacteur Production De Produits Biologiques Maladie De Fabry
PRESS RELEASE published on 08/26/2026 at 23:05, 1 hour 43 minutes ago Biosidus expands biologics manufacturing capacity and strengthens global supply capabilities for agalsidase beta Biosidus expands biologics manufacturing capacity, strengthening global supply capabilities for agalsidase beta through new bioreactor plant, focusing on rare diseases Rare Diseases Biologics Manufacturing Biosidus Bioreactor Plant Agalsidase Beta
Published on 08/27/2026 at 00:05, 43 minutes ago Kidoz Reports Record Q2 2026 Revenue, up 37%, as H1 Revenue Reaches US$6.28 Million (CAD$8.66 Million)
Published on 08/26/2026 at 23:00, 1 hour 48 minutes ago Datametrex Announces Transition to Semi-Annual Financial Reporting
Published on 08/26/2026 at 22:30, 2 hours 18 minutes ago AI/ML Innovations Inc. Closes First Tranche of Private Placement
Published on 08/26/2026 at 22:30, 2 hours 18 minutes ago Blueberries Medical Announces Closing of C$1.1 Million Non-Brokered Private Placement
Published on 08/26/2026 at 21:15, 3 hours 33 minutes ago Announces Private Placement of Convertible Promissory Notes
Published on 08/26/2026 at 23:05, 1 hour 43 minutes ago Biosidus expands biologics manufacturing capacity and strengthens global supply capabilities for agalsidase beta
Published on 08/26/2026 at 18:44, 6 hours 4 minutes ago AUSTRIACARD HOLDINGS AG: Press Release H1 2026 Financial Results
Published on 08/26/2026 at 18:40, 6 hours 8 minutes ago MBC GROUP REVEALS MBC GAMES STUDIO WITH DEBUT TITLE UNVEILING AT GAMESCOM
Published on 08/26/2026 at 18:30, 6 hours 18 minutes ago Heidelberg Pharma AG and Huadong Medicine Receive NMPA Approval for Clinical Trial of HDP-101 Combination Therapy in China
Published on 08/26/2026 at 18:00, 6 hours 48 minutes ago MHM Corporate: reduces the nominal value of its shares to €0.011
Published on 08/26/2026 at 18:02, 6 hours 46 minutes ago Altareit: Altarea press release regarding the Primonial matter
Published on 08/26/2026 at 18:02, 6 hours 46 minutes ago Altareit : Communiqué de presse d’Altarea relatif au dossier Primonial
Published on 08/26/2026 at 18:00, 6 hours 48 minutes ago Altarea: Comprehensive settlement agreement reached, ending the dispute between Altarea and the shareholders of the Praemia group (formerly Primonial group)
Published on 08/26/2026 at 18:00, 6 hours 48 minutes ago Altarea : Conclusion d’un accord global mettant fin au litige entre Altarea et les actionnaires du groupe Praemia (ex-groupe Primonial)
Published on 08/26/2026 at 18:00, 6 hours 48 minutes ago KLARSEN : lance Dimea, sa nouvelle activité e-commerce dédiée aux compléments alimentaires
